InflaRx NV
NASDAQ:IFRX

Watchlist Manager
InflaRx NV Logo
InflaRx NV
NASDAQ:IFRX
Watchlist
Price: 2.03 USD 18.71% Market Closed
Market Cap: 119.5m USD
Have any thoughts about
InflaRx NV?
Write Note

InflaRx NV
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InflaRx NV
Capital Expenditures Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
InflaRx NV
NASDAQ:IFRX
Capital Expenditures
-€87.2k
CAGR 3-Years
-8%
CAGR 5-Years
41%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Capital Expenditures
-€705.5m
CAGR 3-Years
-102%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Capital Expenditures
-€2.5m
CAGR 3-Years
60%
CAGR 5-Years
-1%
CAGR 10-Years
9%
Immatics NV
NASDAQ:IMTX
Capital Expenditures
-€31m
CAGR 3-Years
-60%
CAGR 5-Years
-128%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Capital Expenditures
-€33.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Formycon AG
XETRA:FYB
Capital Expenditures
-€21.2m
CAGR 3-Years
-228%
CAGR 5-Years
-82%
CAGR 10-Years
N/A

See Also

What is InflaRx NV's Capital Expenditures?
Capital Expenditures
-87.2k EUR

Based on the financial report for Jun 30, 2024, InflaRx NV's Capital Expenditures amounts to -87.2k EUR.

What is InflaRx NV's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
41%

Over the last year, the Capital Expenditures growth was 49%. The average annual Capital Expenditures growth rates for InflaRx NV have been -8% over the past three years , 41% over the past five years .

Back to Top